Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
New evidence

Anthocyanidins linked to 16% lower digestive cancer risk — but this is an early umbrella review, not a final answer

This is the first systematic summary to tie anthocyanidins specifically to a reduced risk of digestive system cancers, but because it's an umbrella review of existing meta-analyses, the quality of the underlying studies varies, and the result needs independent replication before it can be considered reliable.

Researchers analyzed multiple meta-analyses on polyphenol intake and digestive system cancers. They found that people who consumed more anthocyanidins — the pigments in berries and red grapes — had a 16% lower risk of developing these cancers. However, this finding comes from a single review of reviews, not a large controlled trial, so the actual benefit could be smaller or even absent.

Where this fits in the evidence

This is among the first studies we've indexed on Anthocyanins for Reduced Risk of Digestive System Cancer — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top